Plasma YKL-40: a BMI-independent marker of type 2 diabetes.
about
Adipose tissue immunity and cancerRevisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolismAssociations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 DiabetesAge-related alterations in retinal neurovascular and inflammatory transcriptsThe chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic ratsSatellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6.Differential proinflammatory and oxidative stress response and vulnerability to metabolic syndrome in habitual high-fat young male consumers putatively predisposed by their genetic backgroundThe Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish populationUtility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies.Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery diseasePlasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy.Inflammation in sleep apnea: an update.Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjectsChitinase-like proteins in lung injury, repair, and metastasisYKL-40 and genetic status of CHI3L1 in a large group of asthmaticsThe impact of acute aerobic exercise on chitinase 3-like protein 1 and intelectin-1 expression in obesity.Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Plasma YKL-40: a potential new cancer biomarker?YKL-40--an emerging biomarker in cardiovascular disease and diabetes.Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome.YKL-40: a new biomarker in cardiovascular disease?Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.Chitinases: in agriculture and human healthcare.Myokines in insulin resistance and type 2 diabetes.Comparative effects of metformin and pioglitazone on YKL-40 in type 2 diabetes: a randomized clinical trial.Role of chitinase-like proteins in cancer.Serum YKL-40 as a potential biomarker of inflammation in psoriasis.Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine.Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects.Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitusCILAIR-Based Secretome Analysis of Obese Visceral and Subcutaneous Adipose Tissues Reveals Distinctive ECM Remodeling and Inflammation Mediators.Plasma YKL-40 levels are elevated in patients with chronic heart failure.The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes.Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
P2860
Q26862654-F84D1824-ABF7-4A25-AD8D-E0D0AE92E43BQ28085224-343516A5-0B81-4051-A6B5-E97A9943C931Q28546703-5FB8B880-B5A0-440B-B17A-83115868A6BEQ28570411-D60F4683-A72F-4287-BDC2-348D416760DDQ34031351-9A410BE0-BBF1-4415-8318-91E5249F6DD5Q34173547-8AD1FB8E-D05E-48EA-9F36-DBFBC4B42907Q34326387-D2CDB105-2F5B-47BD-9882-1A223FAABED8Q34366578-3A69E42E-A76B-47BE-8DA5-95913911A991Q34447892-8D608A25-B9E9-4786-A432-989C06D4C222Q34494109-DE2FB8CB-D51B-415A-B4EE-2276951D9CBAQ34834538-C51F7BE2-ACF5-4819-93E0-4376A5BD8AEEQ35021964-51EC709A-5BF6-4F9F-8292-755D7D3F4E38Q35077055-A11844A2-6028-4343-8391-46CD01A4F47FQ35099967-9586CB5B-F79B-4260-9373-067A4F5AF281Q35137720-2C24EB9F-670C-4EB7-965F-0607076C4B2DQ35557987-30D31FE1-A567-4AFE-B96D-F751A4B96194Q35984042-31157F23-3168-4CD7-892F-93CB713174F8Q36300687-A1C0EF5B-9D60-4D97-9802-CF4235E1E6ACQ37071517-8DB2407F-59F3-461B-BB25-0D345A08CE25Q37330377-2F8D8385-AABC-444C-81D7-2E749D568948Q37334247-FC102BC4-0A34-4DF1-BE99-F29FBD7EB152Q37605869-AEB07954-4E9F-4112-B229-6A0227BB1450Q37636543-45AEA2C1-134B-49C1-9A58-841DCCADC739Q37664564-9C5EB756-8595-4510-94B6-5663F4657FB8Q37779310-244CC880-7274-40B9-9456-7C57A5B1AB25Q37807414-E9912965-9A33-48F8-A90E-7CD8C335D185Q38121922-ACA046B3-B7A2-4627-B0DA-BCC28EC72711Q38199992-901D91C6-FED1-43B7-AB32-E30175B27AE8Q38425185-A8417313-6AA0-4EAF-9EFA-BC31571D668AQ38687563-0302BC05-F629-4077-B23D-2A3BC8D62A81Q40215575-E2E25AFD-748E-4C53-A8B1-6A19181C20E2Q41541741-8EEBA548-5F88-427C-BE1E-2AF1BD7627F0Q42221121-7E1AF314-E679-434E-9991-B1E40EF62511Q42241520-881289C0-BDE3-45AF-9A75-1C4DB10054DCQ42362647-9752D8C2-80D2-47C9-9963-1FD56263407AQ43170207-6119A57B-0351-496E-AB09-FDA3F2EDB2E1Q43229804-78AE62A7-6CA8-4CD8-B543-DD8B12E53F53Q43834139-143BC626-0F9B-418F-A238-7D76FAAC4071Q44099099-AFABD68A-41E9-4C12-97A6-1CE746E78761Q45995592-5748D465-3839-4AAD-A81B-CA1A007B8121
P2860
Plasma YKL-40: a BMI-independent marker of type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Plasma YKL-40: a BMI-independent marker of type 2 diabetes.
@en
type
label
Plasma YKL-40: a BMI-independent marker of type 2 diabetes.
@en
prefLabel
Plasma YKL-40: a BMI-independent marker of type 2 diabetes.
@en
P2093
P2860
P50
P356
P1433
P1476
Plasma YKL-40: a BMI-independent marker of type 2 diabetes.
@en
P2093
Christian Erikstrup
Julia S Johansen
Rikke Krogh-Madsen
Sarah Taudorf
P2860
P304
P356
10.2337/DB08-0182
P407
P577
2008-07-23T00:00:00Z